Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
Janssen Scientific Affairs, LLC
Bruce E Sands; Peter M Irving; Timothy Hoops; James L Izanec; Long-Long Gao; Christopher Gasink; Andrew Greenspan; Matthieu Allez; Silvio Danese; Stephen B Hanauer; Vipul Jairath; Tanja Kuehbacher; James D Lewis; Edward V Loftus; Emese Mihaly; Remo Panaccione; Ellen Scherl; Oksana B Shchukina; William J Sandborn; SEAVUE Study Group
Division of Gastroenterology, Department of Medicine, University Hospital, London, ON, Canada; Division of Epidemiology and Biostatistics, Western University, London, ON, Canada.